Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Jihyun Bae, PharmD
ORISE Fellow
ORISE / US Food & Drug Administration
Poster(s):
A002: A Comparative Review of Study Population & Dose Recommendations for In Vivo Bioequivalence Studies With Pharmacokinetic Endpoints Between FDA & EMA Guidances
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
023: FDA & EMA Regulatory Recommendations on Fed Bioequivalence Study in Healthy Subjects vs Patients for Generic Drug Development
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
